224 related articles for article (PubMed ID: 24495253)
1. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer.
Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L
Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.
Mei S; Ge S; Wang J; Li H; Jing X; Liang K; Zhang X; Xue C; Zhang C; Zhang T
J Pathol Clin Res; 2021 Mar; 7(2):154-164. PubMed ID: 33416213
[TBL] [Abstract][Full Text] [Related]
4. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
[TBL] [Abstract][Full Text] [Related]
6. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
8. Significance of differential expression of OLFM4 in the development of endometrial adenocarcinoma.
Huang D; Li X; Liu Y; Yang J; Liu J; Zhang M; Liu X; Meng Q; Zhang S; Li H
Medicine (Baltimore); 2022 Nov; 101(47):e31858. PubMed ID: 36451436
[TBL] [Abstract][Full Text] [Related]
9. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
11. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
12. Lnc-NA inhibits proliferation and metastasis in endometrioid endometrial carcinoma through regulation of NR4A1.
Sun L; Zhou R; Dong J; Liu S; Jiao Y; Wang L; Hu S; He P; Liu X; Zhao X; Jiang G; Zhao Y
J Cell Mol Med; 2019 Jul; 23(7):4699-4710. PubMed ID: 31050196
[TBL] [Abstract][Full Text] [Related]
13. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas.
Mylonas I
Oncol Rep; 2010 Aug; 24(2):385-93. PubMed ID: 20596625
[TBL] [Abstract][Full Text] [Related]
15. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer.
Singer CF; Kronsteiner N; Marton E; Walter I; Kubista M; Czerwenka K; Schreiber M; Tschugguel W; Wieser F; Kubista E
Gynecol Oncol; 2002 Jun; 85(3):423-30. PubMed ID: 12051868
[TBL] [Abstract][Full Text] [Related]
17. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
Witek A; Paul-Samojedny M; Stojko R; Seifert B; Mazurek U
Gynecol Oncol; 2007 Aug; 106(2):407-12. PubMed ID: 17561234
[TBL] [Abstract][Full Text] [Related]
18. miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.
Li S; Hu R; Wang C; Guo F; Li X; Wang S
Mol Med Rep; 2014 Jun; 9(6):2393-9. PubMed ID: 24715036
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma.
Ye L; Kriegl L; Reiter FP; Munker SM; Itzel T; Teufel A; Ziesch A; Török HP; Kirchner T; Gerbes AL; Guba M; Mayerle J; De Toni EN
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00124. PubMed ID: 31990698
[TBL] [Abstract][Full Text] [Related]
20. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
